{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:59:27Z","timestamp":1771484367255,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["BIC\/12(23)\/2012"],"award-info":[{"award-number":["BIC\/12(23)\/2012"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ijbiomac.2021.01.148","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T11:07:24Z","timestamp":1611400044000},"page":"466-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their neuroprotective properties"],"prefix":"10.1016","volume":"174","author":[{"given":"Chandran","family":"Remya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.V.","family":"Dileep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jayadevi","family":"Variyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam Y.J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.V.","family":"Omkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sadasivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0079-6123(08)62425-5","article-title":"Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer\u2019s dementia","volume":"98","author":"Dunnett","year":"1993","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0010","first-page":"93","article-title":"Possible role of the cholinergic system and disease models","volume":"49","author":"Weinstock","year":"1997","journal-title":"J. Neural Transm. Suppl."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/jama.1997.03540250018010","article-title":"Donepezil approved for treatment of Alzheimer disease","volume":"277","author":"Nightingale","year":"1997","journal-title":"Jama-J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.01.148_bb0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1248\/bpb.18.1145","article-title":"Kinetic-study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-L-Indanon)-2-Yl]methylpiperidine hydrochloride (E2020)","volume":"18","author":"Nochi","year":"1995","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"issue":"22","key":"10.1016\/j.ijbiomac.2021.01.148_bb0030","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.148_bb0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer\u2019s fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1006\/bbrc.1997.6357","article-title":"A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme","volume":"232","author":"Reyes","year":"1997","journal-title":"BiochemBioph Res Co"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0045","first-page":"407","article-title":"beta-amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"BiochemPharmacol"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.148_bb0050","first-page":"817","article-title":"Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer\u2019s disease: do we need new inhibitors?","volume":"10","author":"Small","year":"2005","journal-title":"Expert OpinEmerg Drugs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0055","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","article-title":"The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development","volume":"306","author":"Terry","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.148_bb0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2016.03.017","article-title":"AChE inhibition-based multi-target-directed ligands, a novel pharmacological approach for the symptomatic and disease-modifying therapy of Alzheimer\u2019s disease","volume":"14","author":"Wang","year":"2016","journal-title":"CurrNeuropharmacol"},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejmech.2017.02.045","article-title":"Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors","volume":"133","author":"Lan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.148_bb0070","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bmc.2016.02.023","article-title":"Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer\u2019s disease","volume":"24","author":"Xie","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0075","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejmech.2016.09.057","article-title":"Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"125","author":"Mishra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"24","key":"10.1016\/j.ijbiomac.2021.01.148_bb0085","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1021\/jm200853t","volume":"54","author":"Bolea","year":"2011","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14756366.2018.1545766","article-title":"Donepezil+chromone+ melatonin hybrids as promising agents for Alzheimer\u2019s disease therapy","volume":"34","author":"Pach\u00f3n-Angona","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0095","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/14756366.2018.1491564","article-title":"Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer\u2019s drug candidates","volume":"33","author":"Piemontese","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.148_bb0100","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1021\/acschemneuro.8b00699","article-title":"Novel deoxyvasicinone\u2013donepezil hybrids as potential multitarget drug candidates for Alzheimer\u2019s disease","volume":"10","author":"Du","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.148_bb0105","first-page":"66","article-title":"Alzheimer\u2019s disease drug development pipeline 2020","volume":"7","author":"Sabbagh","year":"2020","journal-title":"Jpad-J PrevAlzheim"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.148_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.01.148_bb0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(03)00502-7","article-title":"Treatment of Alzheimer\u2019s disease: current status and new perspectives","volume":"2","author":"Scarpini","year":"2003","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.01.148_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.jnen.0000228136.58062.bf","article-title":"Involvement of oxidative stress in Alzheimer disease","volume":"65","author":"Nunomura","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.01.148_bb0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12017-009-8091-0","article-title":"Alzheimer\u2019s disease amyloid beta-protein and synaptic function","volume":"12","author":"Ondrejcak","year":"2010","journal-title":"NeuroMolecular Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.58.3.365","article-title":"Glutamate transporters in neurologic disease","volume":"58","author":"Maragakis","year":"2001","journal-title":"Arch. Neurol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2021.01.148_bb0145","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1096\/fasebj.6.15.1464368","article-title":"Mechanisms of excitotoxicity in neurologic diseases","volume":"6","author":"Beal","year":"1992","journal-title":"FASEB J."},{"issue":"1464","key":"10.1016\/j.ijbiomac.2021.01.148_bb0150","first-page":"2255","article-title":"Ca2+ signals and death programmes in neurons","volume":"360","author":"Berliocchi","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0160","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2133\/dmpk.DMPK-11-PF-903","article-title":"The blood-brain barrier as a focus of drug metabolism and pharmacokinetics research","volume":"26","author":"Deguchi","year":"2011","journal-title":"Drug MetabPharmacok"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tiv.2004.06.011","article-title":"In vitro models for the blood-brain barrier","volume":"19","author":"Garberg","year":"2005","journal-title":"Toxicol. in Vitro"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-004-1377-8","article-title":"Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology","volume":"25","author":"Deli","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0175","first-page":"307","article-title":"An overview of in vitro techniques for blood-brain barrier studies","volume":"89","author":"Reichel","year":"2003","journal-title":"Methods Mol Med"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0180","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00894-012-1656-0","article-title":"In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile","volume":"19","author":"Remya","year":"2013","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0185","doi-asserted-by":"crossref","unstructured":"G.L. Ellman, K.D. Courtney, V. Andres, R.M. Featherstone, A new and rapid colorimetric determination of acetylcholinesterase activity, BiochemPharmacol 7(2) (1961) 88-&.","DOI":"10.1016\/0006-2952(61)90145-9"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.148_bb0190","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1152\/ajpendo.1978.235.2.E97","article-title":"Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves","volume":"235","author":"DeLean","year":"1978","journal-title":"Am J Physiol Endocrinol"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmpb.2006.01.008","article-title":"Robust regression for high throughput drug screening","volume":"82","author":"Fomenko","year":"2006","journal-title":"Comp Meth Prog Bio"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.148_bb0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0306-4522(86)90253-8","article-title":"Microtubule-associated protein-2 and tubulin are differently distributed in the dendrites of developing neurons","volume":"17","author":"Matus","year":"1986","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4886(95)90002-0","article-title":"Protective effects of Bdnf and Nt-3 but not Pdgf against hypoglycemic injury to cultured striatal neurons","volume":"131","author":"Nakao","year":"1995","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.01.148_bb0210","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1471-4159.1998.71030946.x","article-title":"Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons","volume":"71","author":"Tenneti","year":"1998","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.01.148_bb0215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0165-6147(00)89070-7","article-title":"Nmda receptor-dependent excitotoxicity - the role of intracellular Ca2(+) release","volume":"16","author":"Mody","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.01.148_bb0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous-system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.01.148_bb0225","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1523\/JNEUROSCI.13-05-02085.1993","article-title":"Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons","volume":"13","author":"Tymianski","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.82","article-title":"NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors","volume":"4","author":"Zhou","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0235","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/gps.938","article-title":"The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence","volume":"18","author":"Danysz","year":"2003","journal-title":"Int J Geriatr Psych"},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ceca.2018.05.009","article-title":"A simple end-point assay for calcium channel activity","volume":"74","author":"Chandrika","year":"2018","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(97)00556-8","article-title":"Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha (7)-neuronal receptors and neuronal CNS receptors","volume":"765","author":"Kaneko","year":"1997","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.148_bb0250","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/jpet.103.050104","article-title":"Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons","volume":"306","author":"Takada","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0255","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/870389","article-title":"Virtual screening of acetylcholinesterase inhibitors using Lipinski\u2019s rule of five and ZINC databank","volume":"2015","author":"Nogara","year":"2015","journal-title":"BioMed Res Int"},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.01.148_bb0260","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00044-011-9814-y","article-title":"An in silico approach for the identification of inhibitors against acetylcholinesterase","volume":"21","author":"Remya","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0265","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1080\/14756366.2018.1458031","article-title":"Novel hits for acetylcholinesterase inhibition derived by docking-based screening on ZINC database","volume":"33","author":"Doytchinova","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.01.148_bb0270","first-page":"737","article-title":"Search for potential cholinesterase inhibitors from the ZINC database by virtual screening method","volume":"72","author":"Bajda","year":"2015","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0275","first-page":"40","article-title":"Acetylcholinesterase inhibitors selected by docking-based screening\u2013proof-of-concept study","volume":"50","author":"Stavrakov","year":"2018","journal-title":"Bulg. Chem. Commun."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.01.148_bb0280","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/slct.201904177","article-title":"Novel acetylcholinesterase inhibitors identified from ZINC database using docking-based virtual screening for Alzheimer\u2019s disease","volume":"5","author":"Abdusalam","year":"2020","journal-title":"ChemistrySelect"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.01.148_bb0285","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1358\/mf.2000.22.8.701373","article-title":"Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro","volume":"22","author":"Ogura","year":"2000","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.01.148_bb0290","first-page":"409","article-title":"Inhibitory action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase: comparison with other inhibitors","volume":"2","author":"Yamanishi","year":"1991","journal-title":"Basec, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.148_bb0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(94)91678-0","article-title":"Nicotine-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity","volume":"644","author":"Akaike","year":"1994","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.01.148_bb0300","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(92)91691-7","article-title":"Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity","volume":"592","author":"Tamura","year":"1992","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1476-5381.2010.00894.x","article-title":"Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of \u03b17 nicotinic receptors and internalization of NMDA receptors","volume":"161","author":"Shen","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.01.148_bb0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.410420205","article-title":"Nicotinic receptor stimulation protects neurons against \u03b2-amyloid toxicity","volume":"42","author":"Kihara","year":"1997","journal-title":"Ann Neuro"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.01.148_bb0315","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1471-4159.2009.06447.x","article-title":"ACh receptors link two signaling pathways to neuroprotection against glutamate-induced excitotoxicity in isolated RGCs","volume":"112","author":"Asomugha","year":"2010","journal-title":"J. Neurochem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302100180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302100180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:42:11Z","timestamp":1758876131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302100180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":63,"alternative-id":["S014181302100180X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.148","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their neuroprotective properties","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}